adplus-dvertising
Connect with us

Investment

What has the investment community excited about in 2022? – The Science Board

Published

 on


Cavazos began by telling ScienceBoard editor in chief, Samantha Black, PhD that 2021 was one of the worst years in biotech regarding investments since 2006.

“Some of the macro factors have been having an impact on the weakness… of the sector,” he said. “And then some company-specific events, particularly in Q4, really put a lot of pressure on the XDI biotech index. More broadly, we had a number of high-profile failures within year, which really have had an impact on investor sentiment.”

Video loading …

In spite of the tumultuous environment in 2021, it was still a record year for biopharma IPOs. Cavazos listed the following as indicators of success and enthusiasm from the investment community:

  • In the first half of the year alone there were over 75 initial public offerings (IPOs) in biopharma, realizing $14.7 billion
  • 80 crossovers deals (venture financings in which there is significant participation from investors that typically buy into publicly traded companies or IPOs)
  • Oncology, rare diseases and central nervous system diseases led in terms of dollars following into the market
  • Companies achieved over 80% of redemptions and 75 in the pipeline (the return of an investor’s principal on a fixed income security such as a bond, mutual fund or preferred stock)
  • Currently 80 special-purpose acquisition company (SPACs; 43 life sciences, $2 billion expiring in 2022)
  • Several large pharmaceutical companies have patent expirations coming up ($125 billion in lost revenue expected in 2022)
  • $200 billion in revenue coming from COVID-related sales

In 2022 investors expect a shift away from preclinical companies to companies with catalyst data that drives stock market prices, Cavazos commented. His team estimates 500 billion in cash available for acquisitions, share buybacks, and internal investments. They expect 2022 to be very active and hope to see an uptick deal-making, volume, and dollar value.

“And I think that’s where those markets are going, establishing proof of concept in smaller, more niche patient populations,” he explained. “And then leveraging that success and broadening it to much larger indications, more chronic indications with a larger percentage of the population.”

SVB Leerink is a healthcare-dedicated investment bank that has over 145 investment bankers focused on healthcare. They advise and work with biotech companies to help them raise equity investments for growth and innovation.

Do you have a unique perspective on your research related to biotech finance? Contact the editor today to learn more.

Related Reading

Top PE investments in biotools in 2021
2021 was an especially active year for private equity (PE) firms. According to PitchBook, the number of deals surged over 51% last year to top 8,600….

Copyright © 2022 scienceboard.net

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Economy

Energy stocks help lift S&P/TSX composite, U.S. stock markets also up

Published

 on

 

TORONTO – Canada’s main stock index was higher in late-morning trading, helped by strength in energy stocks, while U.S. stock markets also moved up.

The S&P/TSX composite index was up 34.91 points at 23,736.98.

In New York, the Dow Jones industrial average was up 178.05 points at 41,800.13. The S&P 500 index was up 28.38 points at 5,661.47, while the Nasdaq composite was up 133.17 points at 17,725.30.

The Canadian dollar traded for 73.56 cents US compared with 73.57 cents US on Monday.

The November crude oil contract was up 68 cents at US$69.70 per barrel and the October natural gas contract was up three cents at US$2.40 per mmBTU.

The December gold contract was down US$7.80 at US$2,601.10 an ounce and the December copper contract was up a penny at US$4.28 a pound.

This report by The Canadian Press was first published Sept. 17, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX gains almost 100 points, U.S. markets also higher ahead of rate decision

Published

 on

 

TORONTO – Strength in the base metal and technology sectors helped Canada’s main stock index gain almost 100 points on Friday, while U.S. stock markets climbed to their best week of the year.

“It’s been almost a complete opposite or retracement of what we saw last week,” said Philip Petursson, chief investment strategist at IG Wealth Management.

In New York, the Dow Jones industrial average was up 297.01 points at 41,393.78. The S&P 500 index was up 30.26 points at 5,626.02, while the Nasdaq composite was up 114.30 points at 17,683.98.

The S&P/TSX composite index closed up 93.51 points at 23,568.65.

While last week saw a “healthy” pullback on weaker economic data, this week investors appeared to be buying the dip and hoping the central bank “comes to the rescue,” said Petursson.

Next week, the U.S. Federal Reserve is widely expected to cut its key interest rate for the first time in several years after it significantly hiked it to fight inflation.

But the magnitude of that first cut has been the subject of debate, and the market appears split on whether the cut will be a quarter of a percentage point or a larger half-point reduction.

Petursson thinks it’s clear the smaller cut is coming. Economic data recently hasn’t been great, but it hasn’t been that bad either, he said — and inflation may have come down significantly, but it’s not defeated just yet.

“I think they’re going to be very steady,” he said, with one small cut at each of their three decisions scheduled for the rest of 2024, and more into 2025.

“I don’t think there’s a sense of urgency on the part of the Fed that they have to do something immediately.

A larger cut could also send the wrong message to the markets, added Petursson: that the Fed made a mistake in waiting this long to cut, or that it’s seeing concerning signs in the economy.

It would also be “counter to what they’ve signaled,” he said.

More important than the cut — other than the new tone it sets — will be what Fed chair Jerome Powell has to say, according to Petursson.

“That’s going to be more important than the size of the cut itself,” he said.

In Canada, where the central bank has already cut three times, Petursson expects two more before the year is through.

“Here, the labour situation is worse than what we see in the United States,” he said.

The Canadian dollar traded for 73.61 cents US compared with 73.58 cents US on Thursday.

The October crude oil contract was down 32 cents at US$68.65 per barrel and the October natural gas contract was down five cents at US$2.31 per mmBTU.

The December gold contract was up US$30.10 at US$2,610.70 an ounce and the December copper contract was up four cents US$4.24 a pound.

— With files from The Associated Press

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX composite down more than 200 points, U.S. stock markets also fall

Published

 on

 

TORONTO – Canada’s main stock index was down more than 200 points in late-morning trading, weighed down by losses in the technology, base metal and energy sectors, while U.S. stock markets also fell.

The S&P/TSX composite index was down 239.24 points at 22,749.04.

In New York, the Dow Jones industrial average was down 312.36 points at 40,443.39. The S&P 500 index was down 80.94 points at 5,422.47, while the Nasdaq composite was down 380.17 points at 16,747.49.

The Canadian dollar traded for 73.80 cents US compared with 74.00 cents US on Thursday.

The October crude oil contract was down US$1.07 at US$68.08 per barrel and the October natural gas contract was up less than a penny at US$2.26 per mmBTU.

The December gold contract was down US$2.10 at US$2,541.00 an ounce and the December copper contract was down four cents at US$4.10 a pound.

This report by The Canadian Press was first published Sept. 6, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending